Targeting white, brown and perivascular adipose tissue in atherosclerosis development

European Journal of Pharmacology

Volumn 816, Issue , 2017, Pages 82-92

  van Dam, Andrea D ^a,b   Boon, Mariëtte R ^a,b   Berbée, Jimmy F P ^a,b   Rensen, Patrick C N ^a,b   van Harmelen, Vanessa ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Einthoven Laboratory of Experimental Vascular Medicine   (Netherlands)

Author keywords

Atherosclerosis; Brown adipose tissue; Inflammation; Lipid metabolism; Obesity; Perivascular adipose tissue; Triglycerides; White adipose tissue

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADENOVIRUS VECTOR; ADIPONECTIN; CHYLOMICRON; FATTY ACID; GLITAZONE DERIVATIVE; METFORMIN; PIOGLITAZONE; RIVOGLITAZONE; ROSIGLITAZONE; SALICYLIC ACID DERIVATIVE; SALSALATE; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BEIGE ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; DRUG TARGETING; FATTY ACID SYNTHESIS; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LIPID STORAGE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; RISK FACTOR; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD VESSEL; DRUG EFFECT; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROCEDURES;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 85016449953     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2017.03.051     Document Type: Article

References (169)

1. Abate, N., Garg, A., Peshock, R.M., Stray-Gundersen, J., Grundy, S.M., Relationships of generalized and regional adiposity to insulin sensitivity in men. J. Clin. Investig. 96 (1995), 88–98.
2. Arner, P., Bernard, S., Salehpour, M., Possnert, G., Liebl, J., Steier, P., Buchholz, B.A., Eriksson, M., Arner, E., Hauner, H., Skurk, T., Ryden, M., Frayn, K.N., Spalding, K.L., Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 478 (2011), 110–113.
3. Bartelt, A., Heeren, J., Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 10 (2014), 24–36.
4. Bartelt, A., Bruns, O.T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M.G., Tromsdorf, U.I., Weller, H., Waurisch, C., Eychmuller, A., Gordts, P.L., Rinninger, F., Bruegelmann, K., Freund, B., Nielsen, P., Merkel, M., Heeren, J., Brown adipose tissue activity controls triglyceride clearance. Nat. Med. 17 (2011), 200–205.
5. Bartelt, A., Weigelt, C., Cherradi, M.L., Niemeier, A., Todter, K., Heeren, J., Scheja, L., Effects of adipocyte lipoprotein lipase on de novo lipogenesis and white adipose tissue browning. Biochim. Et. Biophys. Acta 1831 (2013), 934–942.
6. Bartness, T.J., Shrestha, Y.B., Vaughan, C.H., Schwartz, G.J., Song, C.K., Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Mol. Cell. Endocrinol. 318 (2010), 34–43.
7. Berbée, J.F., van der Hoogt, C.C., Sundararaman, D., Havekes, L.M., Rensen, P.C., Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J. Lipid Res. 46 (2005), 297–306.
8. Berbée, J.F., van der Hoogt, C.C., Kleemann, R., Schippers, E.F., Kitchens, R.L., van Dissel, J.T., Bakker-Woudenberg, I.A., Havekes, L.M., Rensen, P.C., Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 20 (2006), 2162–2164.
9. Berbée, J.F., Boon, M.R., Khedoe, P.P., Bartelt, A., Schlein, C., Worthmann, A., Kooijman, S., Hoeke, G., Mol, I.M., John, C., Jung, C., Vazirpanah, N., Brouwers, L.P., Gordts, P.L., Esko, J.D., Hiemstra, P.S., Havekes, L.M., Scheja, L., Heeren, J., Rensen, P.C., Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat. Commun., 6, 2015, 6356.
10. Berg, A.H., Scherer, P.E., Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96 (2005), 939–949.
11. van den Berg, S.M., van Dam, A.D., Rensen, P.C., de Winther, M.P., Lutgens, E., Immune modulation of brown(ing) adipose tissue in obesity. Endocr. Rev., 2016 (er20161066).
12. Bi, P., Shan, T., Liu, W., Yue, F., Yang, X., Liang, X.R., Wang, J., Li, J., Carlesso, N., Liu, X., Kuang, S., Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat. Med. 20 (2014), 911–918.
13. Bodary, P.F., Gu, S., Shen, Y., Hasty, A.H., Buckler, J.M., Eitzman, D.T., Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 25 (2005), e119–e122.
14. Boon, M.R., van den Berg, S.A., Wang, Y., van den Bossche, J., Karkampouna, S., Bauwens, M., De Saint-Hubert, M., van der Horst, G., Vukicevic, S., de Winther, M.P., Havekes, L.M., Jukema, J.W., Tamsma, J.T., van der Pluijm, G., van Dijk, K.W., Rensen, P.C., BMP7 activates brown adipose tissue and reduces diet-induced obesity only at subthermoneutrality. PloS One, 8, 2013, e74083.
15. Boon, M.R., Kooijman, S., van Dam, A.D., Pelgrom, L.R., Berbée, J.F., Visseren, C.A., van Aggele, R.C., van den Hoek, A.M., Sips, H.C., Lombes, M., Havekes, L.M., Tamsma, J.T., Guigas, B., Meijer, O.C., Jukema, J.W., Rensen, P.C., Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 28 (2014), 5361–5375.
16. Bouloumie, A., Marumo, T., Lafontan, M., Busse, R., Leptin induces oxidative stress in human endothelial cells. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 13 (1999), 1231–1238.
17. Boyle, J.G., Logan, P.J., Jones, G.C., Small, M., Sattar, N., Connell, J.M., Cleland, S.J., Salt, I.P., AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia 54 (2011), 1799–1809.
18. Brestoff, J.R., Kim, B.S., Saenz, S.A., Stine, R.R., Monticelli, L.A., Sonnenberg, G.F., Thome, J.J., Farber, D.L., Lutfy, K., Seale, P., Artis, D., Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519 (2015), 242–246.
19. Broeders, E.P., Vijgen, G.H., Havekes, B., Bouvy, N.D., Mottaghy, F.M., Kars, M., Schaper, N.C., Schrauwen, P., Brans, B., van Marken Lichtenbelt, W.D., Thyroid hormone activates brown adipose tissue and increases non-Shivering thermogenesis-A cohort study in a Group of Thyroid carcinoma patients. PloS One, 11, 2016, e0145049.
20. Cannon, B., Nedergaard, J., Brown adipose tissue: function and physiological significance. Physiol. Rev. 84 (2004), 277–359.
21. Cao, H., Adipocytokines in obesity and metabolic disease. J. Endocrinol. 220 (2014), T47–T59.
22. Cariou, B., Charbonnel, B., Staels, B., Thiazolidinediones and PPARgamma agonists: time for a reassessment. Trends Endocrinol. Metab.: TEM 23 (2012), 205–215.
23. Carriere, A., Jeanson, Y., Berger-Muller, S., Andre, M., Chenouard, V., Arnaud, E., Barreau, C., Walther, R., Galinier, A., Wdziekonski, B., Villageois, P., Louche, K., Collas, P., Moro, C., Dani, C., Villarroya, F., Casteilla, L., Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure. Diabetes 63 (2014), 3253–3265.
24. Chang, L., Villacorta, L., Li, R., Hamblin, M., Xu, W., Dou, C., Zhang, J., Wu, J., Zeng, R., Chen, Y.E., Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 126 (2012), 1067–1078.
25. Chatterjee, T.K., Stoll, L.L., Denning, G.M., Harrelson, A., Blomkalns, A.L., Idelman, G., Rothenberg, F.G., Neltner, B., Romig-Martin, S.A., Dickson, E.W., Rudich, S., Weintraub, N.L., Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ. Res. 104 (2009), 541–549.
26. Chevalier, C., Stojanovic, O., Colin, D.J., Suarez-Zamorano, N., Tarallo, V., Veyrat-Durebex, C., Rigo, D., Fabbiano, S., Stevanovic, A., Hagemann, S., Montet, X., Seimbille, Y., Zamboni, N., Hapfelmeier, S., Trajkovski, M., Gut microbiota orchestrates energy homeostasis during cold. Cell 163 (2015), 1360–1374.
27. Chondronikola, M., Volpi, E., Borsheim, E., Porter, C., Saraf, M.K., Annamalai, P., Yfanti, C., Chao, T., Wong, D., Shinoda, K., Labbe, S.M., Hurren, N.M., Cesani, F., Kajimura, S., Sidossis, L.S., Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans. Cell Metab. 23 (2016), 1200–1206.
28. Chung, E.S., Packer, M., Lo, K.H., Fasanmade, A.A., Willerson, J.T., Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive heart failure (ATTACH) trial. Circulation 107 (2003), 3133–3140.
29. Cinti, S., The adipose organ. Prostaglandins, Leukot., Essent. Fat. Acids 73 (2005), 9–15.
30. Cinti, S., Transdifferentiation properties of adipocytes in the adipose organ. Am. J. Physiol. Endocrinol. Metab. 297 (2009), E977–E986.
31. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S., Obin, M.S., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46 (2005), 2347–2355.
32. Cypess, A.M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A.B., Kuo, F.C., Palmer, E.L., Tseng, Y.H., Doria, A., Kolodny, G.M., Kahn, C.R., Identification and importance of brown adipose tissue in adult humans. New Engl. J. Med. 360 (2009), 1509–1517.
33. Cypess, A.M., Weiner, L.S., Roberts-Toler, C., Franquet Elia, E., Kessler, S.H., Kahn, P.A., English, J., Chatman, K., Trauger, S.A., Doria, A., Kolodny, G.M., Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist. Cell Metab. 21 (2015), 33–38.
34. De Lorenzo, F., Mukherjee, M., Kadziola, Z., Sherwood, R., Kakkar, V.V., Central Cooling Effects in Patients with Hypercholesterolaemia, 95, 1998, Clinical science, London, England, 213–217.
35. de Vries-van der Weij, J., Toet, K., Zadelaar, S., Wielinga, P.Y., Kleemann, R., Rensen, P.C., Kooistra, T., Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-kappaB activity and lowering of cholesterol. Atherosclerosis 213 (2010), 241–246.
36. Dessy, C., Balligand, J.L., Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Adv. Pharmacol. (San. Diego, Calif. ) 59 (2010), 135–163.
37. Dijk, W., Heine, M., Vergnes, L., Boon, M.R., Schaart, G., Hesselink, M.K., Reue, K., van Marken Lichtenbelt, W.D., Olivecrona, G., Rensen, P.C., Heeren, J., Kersten, S., ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure. eLife, 2015, 4.
38. Dong, M., Yang, X., Lim, S., Cao, Z., Honek, J., Lu, H., Zhang, C., Seki, T., Hosaka, K., Wahlberg, E., Yang, J., Zhang, L., Lanne, T., Sun, B., Li, X., Liu, Y., Zhang, Y., Cao, Y., Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab. 18 (2013), 118–129.
39. Doniach, D., Possible Stimulation of Thermogenesis in Brown Adipose Tissue by Thyroid-stimulating Hormone, 2, 1975, Lancet, London, England, 160–161.
40. Ebbert, J.O., Jensen, M.D., Fat depots, free fatty acids, and dyslipidemia. Nutrients 5 (2013), 498–508.
41. Exley, M.A., Hand, L., O'Shea, D., Lynch, L., Interplay between the immune system and adipose tissue in obesity. J. Endocrinol. 223 (2014), R41–R48.
42. Fabbiano, S., Suarez-Zamorano, N., Rigo, D., Veyrat-Durebex, C., Stevanovic Dokic, A., Colin, D.J., Trajkovski, M., Caloric restriction leads to browning of white adipose tissue through type 2 immune signaling. Cell Metab. 24 (2016), 434–446.
43. Fedorenko, A., Lishko, P.V., Kirichok, Y., Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 151 (2012), 400–413.
44. Finegold, J.A., Asaria, P., Francis, D.P., Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int. J. Cardiol. 168 (2013), 934–945.
45. Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J.S., Maratos-Flier, E., Spiegelman, B.M., FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26 (2012), 271–281.
46. Fitzgibbons, T.P., Kogan, S., Aouadi, M., Hendricks, G.M., Straubhaar, J., Czech, M.P., Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation.American journal of physiology. Heart Circ. Physiol. 301 (2011), H1425–H1437.
47. Fox, C.S., Pencina, M.J., Wilson, P.W., Paynter, N.P., Vasan, R.S., D'Agostino, R.B. Sr., Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care 31 (2008), 1582–1584.
48. Frayn, K.N., Visceral fat and insulin resistance-causative or correlative?. Br. J. Nutr. 83:Suppl 1 (2000), S71–S77.
49. Garcia-Arcos, I., Hiyama, Y., Drosatos, K., Bharadwaj, K.G., Hu, Y., Son, N.H., O'Byrne, S.M., Chang, C.L., Deckelbaum, R.J., Takahashi, M., Westerterp, M., Obunike, J.C., Jiang, H., Yagyu, H., Blaner, W.S., Goldberg, I.J., Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology. J. Biol. Chem. 288 (2013), 14046–14058.
50. Geerling, J.J., Boon, M.R., van der Zon, G.C., van den Berg, S.A., van den Hoek, A.M., Lombes, M., Princen, H.M., Havekes, L.M., Rensen, P.C., Guigas, B., Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 63 (2014), 880–891.
51. Ghantous, C.M., Azrak, Z., Hanache, S., Abou-Kheir, W., Zeidan, A., Differential role of leptin and adiponectin in cardiovascular system. Int. J. Endocrinol., 2015, 2015, 534320.
52. Goldberg, I.J., Eckel, R.H., McPherson, R., Triglycerides and heart disease: still a hypothesis?. Arterioscler., Thromb., Vasc. Biol. 31 (2011), 1716–1725.
53. Goldberg, R.B., Kendall, D.M., Deeg, M.A., Buse, J.B., Zagar, A.J., Pinaire, J.A., Tan, M.H., Khan, M.A., Perez, A.T., Jacober, S.J., A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 28 (2005), 1547–1554.
54. Gomez-Hernandez, A., Beneit, N., Escribano, O., Diaz-Castroverde, S., Garcia-Gomez, G., Fernandez, S., Benito, M., Severe brown fat lipoatrophy aggravates atherosclerotic process in male mice. Endocrinology 157 (2016), 3517–3528.
55. Goodarzi, M.O., Bryer-Ash, M., Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes, Obes. Metab. 7 (2005), 654–665.
56. Gordts, P.L., Nock, R., Son, N.H., Ramms, B., Lew, I., Gonzales, J.C., Thacker, B.E., Basu, D., Lee, R.G., Mullick, A.E., Graham, M.J., Goldberg, I.J., Crooke, R.M., Witztum, J.L., Esko, J.D., ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors. J. Clin. Investig. 126 (2016), 2855–2866.
57. Grant, R.W., Dixit, V.D., Adipose Tissue as an Immunological Organ. Obesity, 23, 2015, Silver Spring, Md., 512–518.
58. Greenstein, A.S., Khavandi, K., Withers, S.B., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A.P., Pemberton, P.W., Malik, R.A., Heagerty, A.M., Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119 (2009), 1661–1670.
59. Grosskopf, I., Shaish, A., Afek, A., Shemesh, S., Harats, D., Kamari, Y., Apolipoprotein A-V modulates multiple atherogenic mechanisms in a mouse model of disturbed clearance of triglyceride-rich lipoproteins. Atherosclerosis 224 (2012), 75–83.
60. de Haan, W., van der Hoogt, C.C., Westerterp, M., Hoekstra, M., Dallinga-Thie, G.M., Princen, H.M., Romijn, J.A., Jukema, J.W., Havekes, L.M., Rensen, P.C., Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden. CETP mice. Atherosclerosis 197 (2008), 57–63.
61. Hanefeld, M., The role of pioglitazone in modifying the atherogenic lipoprotein profile. Diabetes Obes. Metab. 11 (2009), 742–756.
62. Hansson, G.K., Hermansson, A., The immune system in atherosclerosis. Nat. Immunol. 12 (2011), 204–212.
63. Henrichot, E., Juge-Aubry, C.E., Pernin, A., Pache, J.C., Velebit, V., Dayer, J.M., Meda, P., Chizzolini, C., Meier, C.A., Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler., Thromb., Vasc. Biol. 25 (2005), 2594–2599.
64. Hiramatsu-Ito, M., Shibata, R., Ohashi, K., Uemura, Y., Kanemura, N., Kambara, T., Enomoto, T., Yuasa, D., Matsuo, K., Ito, M., Hayakawa, S., Ogawa, H., Otaka, N., Kihara, S., Murohara, T., Ouchi, N., Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovasc. Res. 110 (2016), 107–117.
65. Hiuge-Shimizu, A., Maeda, N., Hirata, A., Nakatsuji, H., Nakamura, K., Okuno, A., Kihara, S., Funahashi, T., Shimomura, I., Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone. Arterioscler., Thromb., Vasc. Biol. 31 (2011), 792–799.
66. Hoeke, G., Kooijman, S., Boon, M.R., Rensen, P.C., Berbée, J.F., Role of brown fat in lipoprotein metabolism and atherosclerosis. Circ. Res. 118 (2016), 173–182.
67. Hoffstedt, J., Arner, P., Hellers, G., Lonnqvist, F., Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J. Lipid Res. 38 (1997), 795–804.
68. Hotamisligil, G.S., Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 54:Suppl 2 (2005), S73–S78.
69. Hotamisligil, G.S., Inflammation and metabolic disorders. Nature 444 (2006), 860–867.
70. Hung, C.M., Calejman, C.M., Sanchez-Gurmaches, J., Li, H., Clish, C.B., Hettmer, S., Wagers, A.J., Guertin, D.A., Rictor/mTORC2 loss in the Myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease. Cell Rep. 8 (2014), 256–271.
71. Jacobsson, L.T., Turesson, C., Gulfe, A., Kapetanovic, M.C., Petersson, I.F., Saxne, T., Geborek, P., Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J. Rheumatol. 32 (2005), 1213–1218.
72. Jensen, M.D., Haymond, M.W., Rizza, R.A., Cryer, P.E., Miles, J.M., Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Investig. 83 (1989), 1168–1173.
73. Kannel, W.B., Vasan, R.S., Triglycerides as vascular risk factors: new epidemiologic insights. Curr. Opin. Cardiol. 24 (2009), 345–350.
74. Karalis, I., Rensen, P.C., Jukema, J.W., Journey through cholesteryl ester transfer protein inhibition: from bench to bedside. Circulation. Cardiovascular quality and outcomes, 6, 2013, 360–366.
75. Karalis, K.P., Giannogonas, P., Kodela, E., Koutmani, Y., Zoumakis, M., Teli, T., Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J. 276 (2009), 5747–5754.
76. Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F.W., Libby, P., Sacks, F.M., Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 114 (2006), 681–687.
77. Kawakami, A., Aikawa, M., Libby, P., Alcaide, P., Luscinskas, F.W., Sacks, F.M., Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation 113 (2006), 691–700.
78. Kershaw, E.E., Flier, J.S., Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004), 2548–2556.
79. Khan, M.A., St Peter, J.V., Xue, J.L., A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. Diabetes care 25 (2002), 708–711.
80. Khedoe, P.P., Hoeke, G., Kooijman, S., Dijk, W., Buijs, J.T., Kersten, S., Havekes, L.M., Hiemstra, P.S., Berbée, J.F., Boon, M.R., Rensen, P.C., Brown adipose tissue takes up plasma triglycerides mostly after lipolysis. J. Lipid Res. 56 (2015), 51–59.
81. Khovidhunkit, W., Kim, M.S., Memon, R.A., Shigenaga, J.K., Moser, A.H., Feingold, K.R., Grunfeld, C., Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45 (2004), 1169–1196.
82. Kim, S.H., Despres, J.P., Koh, K.K., Obesity and cardiovascular disease: friend or foe?. Eur. Heart J., 2015.
83. Kissebah, A.H., Adams, P.W., Wynn, V., Plasma free fatty acid and triglyceride transport kinetics in man. Clin. Sci. Mol. Med. 47 (1974), 259–278.
84. Klop, B., Elte, J.W., Cabezas, M.C., Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5 (2013), 1218–1240.
85. Kong, X., Banks, A., Liu, T., Kazak, L., Rao, R.R., Cohen, P., Wang, X., Yu, S., Lo, J.C., Tseng, Y.H., Cypess, A.M., Xue, R., Kleiner, S., Kang, S., Spiegelman, B.M., Rosen, E.D., IRF4 is a key thermogenic transcriptional partner of PGC-1alpha. Cell 158 (2014), 69–83.
86. Kooijman, S., Wang, Y., Parlevliet, E.T., Boon, M.R., Edelschaap, D., Snaterse, G., Pijl, H., Romijn, J.A., Rensen, P.C., Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice. Diabetologia 58 (2015), 2637–2646.
87. Kuji, I., Imabayashi, E., Minagawa, A., Matsuda, H., Miyauchi, T., Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma. Ann. Nucl. Med. 22 (2008), 231–235.
88. Kumari, M., Wang, X., Lantier, L., Lyubetskaya, A., Eguchi, J., Kang, S., Tenen, D., Roh, H.C., Kong, X., Kazak, L., Ahmad, R., Rosen, E.D., IRF3 promotes adipose inflammation and insulin resistance and represses browning. J. Clin. Investig. 126 (2016), 2839–2854.
89. Langin, D., Arner, P., Importance of TNFalpha and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol. Metab.: TEM 17 (2006), 314–320.
90. Langin, D., Dicker, A., Tavernier, G., Hoffstedt, J., Mairal, A., Ryden, M., Arner, E., Sicard, A., Jenkins, C.M., Viguerie, N., van Harmelen, V., Gross, R.W., Holm, C., Arner, P., Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54 (2005), 3190–3197.
91. van der Lans, A.A., Hoeks, J., Brans, B., Vijgen, G.H., Visser, M.G., Vosselman, M.J., Hansen, J., Jorgensen, J.A., Wu, J., Mottaghy, F.M., Schrauwen, P., van Marken Lichtenbelt, W.D., Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J. Clin. Investig. 123 (2013), 3395–3403.
92. Lee, J.Y., Zhao, L., Youn, H.S., Weatherill, A.R., Tapping, R., Feng, L., Lee, W.H., Fitzgerald, K.A., Hwang, D.H., Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279 (2004), 16971–16979.
93. Lee, M.H., Chen, S.J., Tsao, C.M., Wu, C.C., Perivascular adipose tissue inhibits endothelial function of rat aortas via caveolin-1. PloS One, 9, 2014, e99947.
94. Lee, M.W., Odegaard, J.I., Mukundan, L., Qiu, Y., Molofsky, A.B., Nussbaum, J.C., Yun, K., Locksley, R.M., Chawla, A., Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160 (2015), 74–87.
95. Libby, P., Inflammation in atherosclerosis. Nature 420 (2002), 868–874.
96. Libby, P., Lichtman, A.H., Hansson, G.K., Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38 (2013), 1092–1104.
97. Lin, J.Z., Martagon, A.J., Cimini, S.L., Gonzalez, D.D., Tinkey, D.W., Biter, A., Baxter, J.D., Webb, P., Gustafsson, J.A., Hartig, S.M., Phillips, K.J., Pharmacological activation of thyroid hormone receptors elicits a functional conversion of white to brown fat. Cell Rep. 13 (2015), 1528–1537.
98. Lohmann, C., Schafer, N., von Lukowicz, T., Sokrates Stein, M.A., Boren, J., Rutti, S., Wahli, W., Donath, M.Y., Luscher, T.F., Matter, C.M., Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. Atherosclerosis 207 (2009), 360–367.
99. Lohn, M., Dubrovska, G., Lauterbach, B., Luft, F.C., Gollasch, M., Sharma, A.M., Periadventitial fat releases a vascular relaxing factor. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 16 (2002), 1057–1063.
100. Mann, D.L., McMurray, J.J., Packer, M., Swedberg, K., Borer, J.S., Colucci, W.S., Djian, J., Drexler, H., Feldman, A., Kober, L., Krum, H., Liu, P., Nieminen, M., Tavazzi, L., van Veldhuisen, D.J., Waldenstrom, A., Warren, M., Westheim, A., Zannad, F., Fleming, T., Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109 (2004), 1594–1602.
101. Maresca, F., Di Palma, V., Bevilacqua, M., Uccello, G., Taglialatela, V., Giaquinto, A., Esposito, G., Trimarco, B., Cirillo, P., Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease. Angiology 66 (2015), 8–24.
102. Mauro, C.R., Ilonzo, G., Nguyen, B.T., Yu, P., Tao, M., Gao, I., Seidman, M.A., Nguyen, L.L., Ozaki, C.K., Attenuated adiposopathy in perivascular adipose tissue compared with subcutaneous human adipose tissue. Am. J. Surg. 206 (2013), 241–244.
103. Mazzone, T., Meyer, P.M., Feinstein, S.B., Davidson, M.H., Kondos, G.T., D'Agostino, R.B. Sr., Perez, A., Provost, J.C., Haffner, S.M., Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. Jama 296 (2006), 2572–2581.
104. Murano, I., Barbatelli, G., Parisani, V., Latini, C., Muzzonigro, G., Castellucci, M., Cinti, S., Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J. Lipid Res. 49 (2008), 1562–1568.
105. Nedergaard, J., Cannon, B., The browning of white adipose tissue: some burning issues. Cell Metab. 20 (2014), 396–407.
106. Nguyen, K.D., Qiu, Y., Cui, X., Goh, Y.P., Mwangi, J., David, T., Mukundan, L., Brombacher, F., Locksley, R.M., Chawla, A., Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480 (2011), 104–108.
107. Nissen, S.E., Wolski, K., Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New Engl. J. Med. 356 (2007), 2457–2471.
108. Nissen, S.E., Nicholls, S.J., Wolski, K., Nesto, R., Kupfer, S., Perez, A., Jure, H., De Larochelliere, R., Staniloae, C.S., Mavromatis, K., Saw, J., Hu, B., Lincoff, A.M., Tuzcu, E.M., Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. Jama 299 (2008), 1561–1573.
109. Nordestgaard, B.G., Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ. Res. 118 (2016), 547–563.
110. Nordestgaard, B.G., Varbo, A., Triglycerides and Cardiovascular Disease, 384, 2014, Lancet, London, England, 626–635.
111. Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., Ohashi, K., Sakai, N., Shimomura, I., Kobayashi, H., Terasaka, N., Inaba, T., Funahashi, T., Matsuzawa, Y., Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106 (2002), 2767–2770.
112. Okuno, A., Tamemoto, H., Tobe, K., Ueki, K., Mori, Y., Iwamoto, K., Umesono, K., Akanuma, Y., Fujiwara, T., Horikoshi, H., Yazaki, Y., Kadowaki, T., Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Investig. 101 (1998), 1354–1361.
113. Oorni, K., Posio, P., Ala-Korpela, M., Jauhiainen, M., Kovanen, P.T., Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans. Arterioscler., Thromb., Vasc. Biol. 25 (2005), 1678–1683.
114. Padilla, J., Jenkins, N.T., Vieira-Potter, V.J., Laughlin, M.H., Divergent phenotype of rat thoracic and abdominal perivascular adipose tissues.American journal of physiology. Regul., Integr. Comp. Physiol. 304 (2013), R543–R552.
115. Park, J.S., Cho, M.H., Nam, J.S., Yoo, J.S., Ahn, C.W., Cha, B.S., Kim, K.R., Lee, H.C., Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. Eur. J. Endocrinol. / Eur. Fed. Endocr. Soc. 164 (2011), 69–74.
116. Pennacchio, L.A., Olivier, M., Hubacek, J.A., Cohen, J.C., Cox, D.R., Fruchart, J.C., Krauss, R.M., Rubin, E.M., An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing, 294, 2001, Science, New York, N.Y, 169–173.
117. Police, S.B., Thatcher, S.E., Charnigo, R., Daugherty, A., Cassis, L.A., Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler., Thromb., Vasc. Biol. 29 (2009), 1458–1464.
118. Puigserver, P., Spiegelman, B.M., Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24 (2003), 78–90.
119. Qian, S.W., Tang, Y., Li, X., Liu, Y., Zhang, Y.Y., Huang, H.Y., Xue, R.D., Yu, H.Y., Guo, L., Gao, H.D., Liu, Y., Sun, X., Li, Y.M., Jia, W.P., Tang, Q.Q., 2013. BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proceedings of the National Academy of Sciences of the United States of America 110, E798-E807.
120. Qiu, Y., Nguyen, K.D., Odegaard, J.I., Cui, X., Tian, X., Locksley, R.M., Palmiter, R.D., Chawla, A., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157 (2014), 1292–1308.
121. Rosenwald, M., Perdikari, A., Rulicke, T., Wolfrum, C., Bi-directional interconversion of brite and white adipocytes. Nat. Cell Biol. 15 (2013), 659–667.
122. Ryden, M., Arner, P., Tumour necrosis factor-alpha in human adipose tissue - from signalling mechanisms to clinical implications. J. Intern. Med. 262 (2007), 431–438.
123. Ryden, M., Andersson, D.P., Bernard, S., Spalding, K., Arner, P., Adipocyte triglyceride turnover and lipolysis in lean and overweight subjects. J. Lipid Res. 54 (2013), 2909–2913.
124. Salpeter, S.R., Buckley, N.S., Kahn, J.A., Salpeter, E.E., Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am. J. Med. 121 (2008), 149–157 (e142).
125. Sanchez-Gurmaches, J., Hung, C.M., Sparks, C.A., Tang, Y., Li, H., Guertin, D.A., PTEN loss in the Myf5 lineage redistributes body fat and reveals subsets of white adipocytes that arise from Myf5 precursors. Cell Metab. 16 (2012), 348–362.
126. Sanchez-Gurmaches, J., Hung, C.M., Guertin, D.A., Emerging complexities in adipocyte origins and identity. Trends Cell Biol. 26 (2016), 313–326.
127. Schipper, H.S., Prakken, B., Kalkhoven, E., Boes, M., Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol. Metab.: TEM 23 (2012), 407–415.
128. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., Flier, J.S., TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Investig. 116 (2006), 3015–3025.
129. Shimizu, I., Aprahamian, T., Kikuchi, R., Shimizu, A., Papanicolaou, K.N., MacLauchlan, S., Maruyama, S., Walsh, K., Vascular rarefaction mediates whitening of brown fat in obesity. J. Clin. Investig. 124 (2014), 2099–2112.
130. Shoelson, S.E., Lee, J., Yuan, M., Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. 27:Suppl 3 (2003), S49–S52.
131. Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J. Clin. Investig. 116 (2006), 1793–1801.
132. Soltis, E.E., Cassis, L.A., Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin. Exp. Hypertens. Part A, Theory Pract. 13 (1991), 277–296.
133. Spalding, K.L., Arner, E., Westermark, P.O., Bernard, S., Buchholz, B.A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Naslund, E., Britton, T., Concha, H., Hassan, M., Ryden, M., Frisen, J., Arner, P., Dynamics of fat cell turnover in humans. Nature 453 (2008), 783–787.
134. Suarez-Zamorano, N., Fabbiano, S., Chevalier, C., Stojanovic, O., Colin, D.J., Stevanovic, A., Veyrat-Durebex, C., Tarallo, V., Rigo, D., Germain, S., Ilievska, M., Montet, X., Seimbille, Y., Hapfelmeier, S., Trajkovski, M., Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat. Med. 21 (2015), 1497–1501.
135. Sun, K., Kusminski, C.M., Luby-Phelps, K., Spurgin, S.B., An, Y.A., Wang, Q.A., Holland, W.L., Scherer, P.E., Brown adipose tissue derived VEGF-A modulates cold tolerance and energy expenditure. Mol. Metab. 3 (2014), 474–483.
136. Takx, R.A., Ishai, A., Truong, Q.A., MacNabb, M.H., Scherrer-Crosbie, M., Tawakol, A., Supraclavicular Brown adipose tissue 18F-FDG uptake and cardiovascular disease. J. Nucl. Med.: Off. Publ., Soc. Nucl. Med. 57 (2016), 1221–1225.
137. Tan, Y.L., Zheng, X.L., Tang, C.K., The protective functions of omentin in cardiovascular diseases. Clin. Chim. Acta; Int. J. Clin. Chem. 448 (2015), 98–106.
138. Tian, X.Y., Ganeshan, K., Hong, C., Nguyen, K.D., Qiu, Y., Kim, J., Tangirala, R.K., Tontonoz, P., Chawla, A., Thermoneutral housing accelerates metabolic inflammation to potentiate atherosclerosis but not insulin resistance. Cell Metab. 23 (2016), 165–178.
139. Timmons, J.A., Wennmalm, K., Larsson, O., Walden, T.B., Lassmann, T., Petrovic, N., Hamilton, D.L., Gimeno, R.E., Wahlestedt, C., Baar, K., Nedergaard, J., Cannon, B., 2007. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. In: Proceedings of the National Academy of Sciences of the United States of America 104, 4401–4406.
140. Trovati, M., Doronzo, G., Barale, C., Vaccheris, C., Russo, I., Cavalot, F., Leptin and vascular smooth muscle cells. Curr. Pharm. Des. 20 (2014), 625–634.
141. UKPDS, Effect of Intensive Blood-glucose Control with Metformin on Complications in Overweight Patients with type 2 Diabetes (UKPDS 34), 352, 1998, Lancet, London, England, 854–865.
142. van Dam, A.D., Nahon, K.J., Kooijman, S., van den Berg, S.M., Kanhai, A.A., Kikuchi, T., Heemskerk, M.M., van Harmelen, V., Lombes, M., van den Hoek, A.M., de Winther, M.P., Lutgens, E., Guigas, B., Rensen, P.C., Boon, M.R., Salsalate activates brown adipose tissue in mice. Diabetes 64 (2015), 1544–1554.
143. van Diepen, J.A., Berbée, J.F., Havekes, L.M., Rensen, P.C., Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis 228 (2013), 306–315.
144. van Harmelen, V., Lonnqvist, F., Thorne, A., Wennlund, A., Large, V., Reynisdottir, S., Arner, P., Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. 21 (1997), 972–979.
145. van Harmelen, V., Dicker, A., Ryden, M., Hauner, H., Lonnqvist, F., Naslund, E., Arner, P., Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51 (2002), 2029–2036.
146. van Marken Lichtenbelt, W.D., Vanhommerig, J.W., Smulders, N.M., Drossaerts, J.M., Kemerink, G.J., Bouvy, N.D., Schrauwen, P., Teule, G.J., Cold-activated brown adipose tissue in healthy men. New Engl. J. Med. 360 (2009), 1500–1508.
147. Villarroya, F., Cereijo, R., Villarroya, J., Giralt, M., Brown adipose tissue as a secretory organ. Nat. Rev. Endocrinol., 2016.
148. Virtanen, K.A., Lidell, M.E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.J., Enerback, S., Nuutila, P., Functional brown adipose tissue in healthy adults. New Engl. J. Med. 360 (2009), 1518–1525.
149. Visser, M., Bouter, L.M., McQuillan, G.M., Wener, M.H., Harris, T.B., Elevated C-reactive protein levels in overweight and obese adults. Jama 282 (1999), 2131–2135.
150. Wang, P., Xu, T.Y., Guan, Y.F., Su, D.F., Fan, G.R., Miao, C.Y., Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc. Res. 81 (2009), 370–380.
151. Wang, S., Liang, X., Yang, Q., Fu, X., Rogers, C.J., Zhu, M., Rodgers, B.D., Jiang, Q., Dodson, M.V., Du, M., Resveratrol induces brown-like adipocyte formation in white fat through activation of amp-activated protein kinase (AMPK) alpha1. Int. J. Obes. 39:2005 (2015), 967–976.
152. Wang, S., Dougherty, E.J., Danner, R.L., PPARgamma signaling and emerging opportunities for improved therapeutics. Pharmacol. Res. 111 (2016), 76–85.
153. Wang, W., Kissig, M., Rajakumari, S., Huang, L., Lim, H.W., Won, K.J., Seale, P., 2014. Ebf2 is a selective marker of brown and beige adipogenic precursor cells. Proceedings of the National Academy of Sciences of the United States of America 111, 14466-14471.
154. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, A.W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 112 (2003), 1796–1808.
155. Westerterp, M., van der Hoogt, C.C., de Haan, W., Offerman, E.H., Dallinga-Thie, G.M., Jukema, J.W., Havekes, L.M., Rensen, P.C., Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice. Arterioscler., Thromb., Vasc. Biol. 26 (2006), 2552–2559.
156. Westerterp, M., Berbée, J.F., Pires, N.M., van Mierlo, G.J., Kleemann, R., Romijn, J.A., Havekes, L.M., Rensen, P.C., Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 116 (2007), 2173–2181.
157. Wong, M.C., van Diepen, J.A., Hu, L., Guigas, B., de Boer, H.C., van Puijvelde, G.H., Kuiper, J., van Zonneveld, A.J., Shoelson, S.E., Voshol, P.J., Romijn, J.A., Havekes, L.M., Tamsma, J.T., Rensen, P.C., Hiemstra, P.S., Berbée, J.F., Hepatocyte-specific IKKbeta expression aggravates atherosclerosis development in APOE*3-Leiden mice. Atherosclerosis 220 (2012), 362–368.
158. Wooton-Kee, C.R., Boyanovsky, B.B., Nasser, M.S., de Villiers, W.J., Webb, N.R., Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler., Thromb., Vasc. Biol. 24 (2004), 762–767.
159. Wu, J., Bostrom, P., Sparks, L.M., Ye, L., Choi, J.H., Giang, A.H., Khandekar, M., Virtanen, K.A., Nuutila, P., Schaart, G., Huang, K., Tu, H., van Marken Lichtenbelt, W.D., Hoeks, J., Enerback, S., Schrauwen, P., Spiegelman, B.M., Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150 (2012), 366–376.
160. Wueest, S., Item, F., Lucchini, F.C., Challa, T.D., Muller, W., Bluher, M., Konrad, D., Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance. Diabetes 65 (2016), 140–148.
161. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 112 (2003), 1821–1830.
162. Yamaga, L.Y., Thom, A.F., Wagner, J., Baroni, R.H., Hidal, J.T., Funari, M.G., The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET/CT in a patient with adrenal pheochromocytoma. Eur. J. Nucl. Med. Mol. Imaging 35 (2008), 446–447.
163. Yamauchi, T., Kadowaki, T., Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes., 32(Suppl 7), 2008 (S13-18).
164. Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauchi, Y., Tobe, K., Miki, H., Tsuchida, A., Akanuma, Y., Nagai, R., Kimura, S., Kadowaki, T., The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 276 (2001), 41245–41254.
165. Yoneshiro, T., Aita, S., Kawai, Y., Iwanaga, T., Saito, M., Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. Am. J. Clin. Nutr. 95 (2012), 845–850.
166. Yoneshiro, T., Aita, S., Matsushita, M., Kayahara, T., Kameya, T., Kawai, Y., Iwanaga, T., Saito, M., Recruited brown adipose tissue as an antiobesity agent in humans. J. Clin. Investig. 123 (2013), 3404–3408.
167. Zierath, J.R., Livingston, J.N., Thorne, A., Bolinder, J., Reynisdottir, S., Lonnqvist, F., Arner, P., Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41 (1998), 1343–1354.
168. Zilversmit, D.B., A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ. Res. 33 (1973), 633–638.
169. Zou, L., Wang, W., Liu, S., Zhao, X., Lyv, Y., Du, C., Su, X., Geng, B., Xu, G., Spontaneous hypertension occurs with adipose tissue dysfunction in perilipin-1 null mice. Biochim. Et. Biophys. Acta 1862 (2016), 182–191.